Good morning, you're listening to Markets Desk.
Intuitive Surgical has shed twenty-eight percent of its value after the company announced it would extend the working lifetime of certain surgical instruments, a move that spooked investors worried about recurring revenue. Goldman Sachs is pushing back hard, telling clients the selloff is overdone and that history consistently rewards patience with this name.
Shifting to consumer staples, Colgate-Palmolive is quietly sitting on a sixty-four year consecutive dividend increase streak, making it one of the most reliable income stories in the entire market. Wall Street has largely looked past it in favor of higher-growth names, but for income investors, that kind of compounding track record is genuinely rare and worth a closer look right now.
And on the international equity side, investors weighing global exposure are facing a straightforward but meaningful choice between two popular ETFs. Schwab's international equity fund charges just three basis points annually, half the cost of Vanguard's total world stock fund, though the Vanguard product does carry broader diversification including domestic exposure alongside international holdings.
That's the tape. Markets Desk, signing off the floor.
